Middle East and Africa Dry Eye Syndrome Market – Industry Trends and Forecast to 2026
Short Description
By Product Type (Tear stimulators, Artificial tears, Secretagogue, Others), Dosage Type (Liquid, Semi-solid, Others), Drug Class (Lubricating Agents, Cholinergics, Anti-Inflammatory, Anti-Infectives, Anti-Allergics, Others), Dose( Unit dose, Multi-dose), Medication Type( Prescription (Rx) Drugs, Over The Counter (OTC) Drugs), Container Type (Unit-Dose Vials, Bottles, Tubes), Packaging Type( Plastic, Aluminium, Glass), Type (Brands, Generics), End Users (Home Healthcare, Hospitals, Clinics, Others), Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Online Pharmacies, Others), Country (South Africa, Rest of Middle East And Africa)
Market Definition:
Dry eye is a multifactorial disease of the tears and ocular surface that causes symptoms of disquiet visual disturbance and tears film variability with possible damage to the ocular surface. It is escorted increase in tear film osmolality and ocular surface inflammation which may result in substantial damage of eye. The symptoms of dry eye syndrome includes eye redness, blurred vision and eye fatigue, watery eyes, which is the body's response to the irritation of dry eyes such as stinging burning and scratchy sensation in eyes.
Market Segmentation:
Middle East And Africa dry eye syndrome market is segmented into ten notable segments which are basis of product type, dosage type, drug class, dose, medication type, container type, packaging type, type, end user and distribution channel.
• On the basis of product type, the market is segmented into tear stimulators, artificial tears, secretagogue and others
• On the basis of dosage type, the market is segmented into liquid, semi solid and others
• On the basis of drug class, the market is segmented into anti-inflammatory, lubricating agents, anti-infectives, anti-allergics, cholinergics and others
• On the basis of dose, the market is segmented into multi dose and unit dose
• On the basis of medication type, the market is segmented into prescription (RX) drugs, and over the counter (OTC) drugs
• On the basis of container type, the market is segmented into unit dose vials, bottles, and tubes
• On the basis of packaging type, the market is segmented into plastic, glass, and aluminium.
• On the basis of type, the market is segmented into generics and brands
• On the basis of end user, the market is segmented into home healthcare, hospitals, clinics, and others
• On the basis of distribution channel, the market is segmented into hospital pharmacies, retail pharmacies, online pharmacies and others
Market Players
• ALLERGAN
• Bausch & Lomb Incorporated
• Novartis AG
• Johnson & Johnson Services, Inc.
• Prestige Consumer Healthcare, Inc.
• AKORN, INC.
• Sun Pharmaceutical Industries Ltd.
• Teva Pharmaceutical Industries Ltd.
• Novaliq GmbH
• Santen Pharmaceutical Co., Ltd.,
• Cardinal Health
• Alembic Pharmaceuticals Limited.
• Cipla Inc.
• Perrigo Company plc
• SENJU PHARMACEUTICAL CO. LTD.
• Horus Pharma
• ROHTO Pharmaceutical Co., Ltd.
• VISUfarma
• Hubrx
The single user license is non-downloadable and non-printable. Global Site license allows these actions.
- 1 Introduction
- 1.1 Objectives Of The Study
- 1.2 Market Definition
- 1.3 Overview Of Middle East And Africa Dry Eye Syndrome Market
- 1.4 Currency And Pricing
- 1.5 Limitations
- 1.6 Markets Covered
- 2 Market Segmentation
- 2.1 Markets Covered
- 2.2 Middle East And Africa Dry Eye Syndrome Market: Geographical Scope
- 2.3 Years Considered For The Study
- 2.4 Currency And Pricing
- 2.5 Dbmr Tripod Data Validation Model
- 2.6 Primary Interviews With Key Opinion Leaders
- 2.7 Dbmr Market Position Grid
- 2.8 Dbmr Vendor Share Analysis
- 2.9 Multivariate Modeling
- 2.10 Products Lifeline Curve
- 2.11 Secondary Sources
- 2.12 Assumptions
- 3 Market Overview
- 3.1 Drivers
- 3.1.1 Increasing Prevalence Of Dry Eye Diseases
- 3.1.2 Changing Geographical Trends To Drive The Market
- 3.1.3 Increasing Awareness About Diagnosis And Treatment Of The Disease
- 3.1.4 Rising Geriatric Population Across The World
- 3.1.5 Increase In Lasik Surgery And Usage Of Contact Lenses
- 3.2 Restraints
- 3.2.1 Stringent Regulatory Process
- 3.2.2 Unmet Medical Needs
- 3.3 Opportunities
- 3.3.1 Emerging Market Presents Significant Opportunities
- 3.3.2 Development Of Novel Technologies
- 3.4 Challenge
- 3.4.1 Increasing Number Of Players
- 4 Executive Summary
- 5 Premium Insights
- 6 Pipeline Analysis
- 6.1 Overview
- 6.2 Marketed Drugs
- 6.3 Approved/Filed Drugs
- 6.4 Phase Iii Trial Candidates
- 6.5 Phase Ii Trial Candidates
- 6.6 Phase I Trial Candidates
- 6.7 Others
- 7 Middle East And Africa Dry Eye Syndrome Market, By Product Type
- 7.1 Overview
- 7.2 Tear Stimulators
- 7.2.1 Pilocarpine
- 7.2.2 Cyclosporine
- 7.2.3 Lifitegrast
- 7.3 Artificial Tears
- 7.3.1 Secretagogue
- 7.3.2 Others
- 8 Middle East And Africa Dry Eye Syndrome Market, By Dosage Type
- 8.1 Overview
- 8.2 Liquid
- 8.2.1 Solutions
- 8.2.2 Emulsions
- 8.2.3 Suspensions
- 8.3 Semi-solid
- 8.3.1 Gel
- 8.3.2 Ointment
- 8.4 Others
- 9 Middle East And Africa Dry Eye Syndrome Market, By Drug Class
- 9.1 Overview
- 9.2 Anti-inflammatory
- 9.3 Lubricating Agent
- 9.4 Anti-infective
- 9.5 Anti-allergic
- 9.6 Cholinergic
- 9.7 Others
- 10 Middle East And Africa Dry Eye Syndrome Market, By Dose
- 10.1 Overview
- 10.2 Multi Dose
- 10.3 Unit Dose
- 11 Middle East And Africa Dry Eye Syndrome Market, By Medication Type
- 11.1 Overview
- 11.2 Prescription (Rx) Drugs
- 11.3 Over The Counter (Otc) Drugs
- 12 Middle East And Africa Dry Eye Syndrome Market, By Container Type
- 12.1 Overview
- 12.2 Unit Dose Vials
- 12.3 Bottles
- 12.4 Tubes
- 13 Middle East And Africa Dry Eye Syndrome Market, By Packaging Type
- 13.1 Overview
- 13.2 Plastic
- 13.3 Glass
- 13.4 Aluminium
- 14 Middle East And Africa Dry Eye Syndrome Market, By Type
- 14.1 Overview
- 14.2 Generic Drug
- 14.3 Branded
- 14.3.1 Restasis
- 14.3.2 Xiidra
- 14.3.3 Refresh
- 14.3.4 Systane
- 14.3.5 Tears Naturale
- 14.3.6 Ikervis
- 14.3.7 Diquas
- 14.3.8 Others
- 15 Middle East And Africa Dry Eye Syndrome Market, By End User
- 15.1 Overview
- 15.2 Home Healthcare
- 15.3 Hospitals
- 15.4 Clinics
- 15.5 Others
- 16 Middle East And Africa Dry Eye Syndrome Market, By Distribution Channel
- 16.1 Overview
- 16.2 Hospital Pharmacies
- 16.3 Retail Pharmacies
- 16.4 Online Pharmacies
- 16.5 Others
- 17 Middle East And Africa Dry Eye Syndrome Market By Geography
- 17.1 Middle East And Africa
- 17.1.1 South Africa
- 17.1.2 Rest Of Middle East And Africa
- 17.1.3 Egypt
- 17.1.4 Saudi Arabia
- 17.1.5 United Arab Emirates
- 17.1.6 Israel
- 18 Middle East And Africa Dry Eye Syndrome Market, Company Landscape
- 18.1 Company Share Analysis: Middle East And Africa
- 19 Swot Analysis
- 19.1 Data Bridge Market Research Analysis-
- 20 Company Profile
- 20.1 Allergan
- 20.1.1 Company Snapshot
- 20.1.2 Revenue Analysis
- 20.1.3 Company Share Analysis
- 20.1.4 Geographical Presence
- 20.1.5 Product Portfolio
- 20.1.6 Recent Developments
- 20.2 Novartis Ag
- 20.2.1 Company Overview
- 20.2.2 Revenue Analysis
- 20.2.3 Company Share Analysis
- 20.2.4 Geographical Presence
- 20.2.5 Product Portfolio
- 20.2.6 Recent Development
- 20.3 Bausch & Lomb Incorporated.
- 20.3.1 Company Snapshot
- 20.3.2 Revenue Analysis
- 20.3.3 Company Share Analysis
- 20.3.4 Geographical Presence
- 20.3.5 Product Portfolio
- 20.3.6 Recent Development
- 20.4 Santen Pharmaceutical Co., Ltd.
- 20.4.1 Company Overview
- 20.4.2 Revenue Analysis
- 20.4.3 Company Share Analysis
- 20.4.4 Geographical Presence
- 20.4.5 Product Portfolio
- 20.4.6 Recent Development
- 20.5 Johnson & Johnson Services, Inc.
- 20.5.1 Company Snapshot
- 20.5.2 Revenue Analysis
- 20.5.3 Company Share Analysis
- 20.5.4 Geographical Presence
- 20.5.5 Product Portfolio
- 20.5.6 Recent Developments
- 20.6 Akorn, Incorporated
- 20.6.1 Company Overview
- 20.6.2 Revenue Analysis
- 20.6.3 Geographical Presence
- 20.6.4 Product Portfolio
- 20.6.5 Recent Development
- 20.7 Alcon Inc
- 20.7.1 Company Snapshot
- 20.7.2 Revenue Analysis
- 20.7.3 Geographical Presence
- 20.7.4 Product Portfolio
- 20.7.5 Recent Development
- 20.8 Alembic Pharmaceuticals Limited
- 20.8.1 Company Snapshot
- 20.8.2 Revenue Analysis
- 20.8.3 Geographical Presence
- 20.8.4 Product Portfolio
- 20.8.5 Recent Developments
- 20.9 Cardinal Health
- 20.9.1 Company Snapshot
- 20.9.2 Revenue Analysis
- 20.9.3 Geographical Presence
- 20.9.4 Product Portfolio
- 20.9.5 Recent Developments
- 20.10 Cipla Inc
- 20.10.1 Company Snapshot
- 20.10.2 Revenue Analysis
- 20.10.3 Geographical Presence
- 20.10.4 Product Portfolio
- 20.10.5 Recent Developments
- 20.11 Horus Pharma
- 20.11.1 Company Overview
- 20.11.2 Geographical Presence
- 20.11.3 Product Portfolio
- 20.11.4 Recent Development
- 20.12 Hubrx
- 20.12.1 Company Snapshot
- 20.12.2 Product Portfolio
- 20.12.3 Recent Developments
- 20.13 Novaliq Gmbh
- 20.13.1 Company Overview
- 20.13.2 Geographical Presence
- 20.13.3 Product Portfolio
- 20.13.4 Recent Development
- 20.14 Perrigo Company Plc
- 20.14.1 Company Snapshot
- 20.14.2 Revenue Analysis
- 20.14.3 Geographical Presence
- 20.14.4 Product Portfolio
- 20.14.5 Recent Development
- 20.15 Prestige Consumer Healthcare, Inc.
- 20.15.1 Company Snapshot
- 20.15.2 Revenue Analysis
- 20.15.3 Product Portfolio
- 20.15.4 Recent Developments
- 20.16 Rohto Pharmaceutical Co., Ltd.
- 20.16.1 Company Snapshot
- 20.16.2 Revenue Analysis
- 20.16.3 Geographical Presence
- 20.16.4 Product Portfolio
- 20.16.5 Recent Development
- 20.17 Senju Pharmaceutical Co. Ltd.
- 20.17.1 Company Overview
- 20.17.2 Revenue Analysis
- 20.17.3 Geographical Presence
- 20.17.4 Product Portfolio
- 20.17.5 Recent Development
- 20.18 Sun Pharmaceutical Industries Ltd.
- 20.18.1 Company Snapshot
- 20.18.2 Revenue Analysis
- 20.18.3 Geographical Presence
- 20.18.4 Product Portfolio
- 20.19 Teva Pharmaceutical Industries Ltd.
- 20.19.1 Company Snapshot
- 20.19.2 Revenue Analysis
- 20.19.3 Geographical Presence
- 20.19.4 Product Portfolio
- 20.19.5 Recent Development
- 20.19.6 Recent Developments
- 20.20 Visufarma
- 20.20.1 Company Overview
- 20.20.2 Geographical Presence
- 20.20.3 Product Portfolio
- 20.20.4 Recent Developments
- 21 References
- 22 Questionnaire
- 23 Related Reports
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook